Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2010
12/14/2010CA2247989C C-c ckr-5,cc-chemokines receptor, derivatives thereof and their uses
12/14/2010CA2205007C Antibody against human interleukin-5 receptor .alpha. chain
12/14/2010CA2192678C Mn gene and protein
12/09/2010WO2010141902A2 METHODS FOR IDENTIFICATION OF SITES FOR IgG CONJUGATION
12/09/2010WO2010141716A2 Methods and materials for diagnosing light chain amyloidosis
12/09/2010WO2010141478A1 Fucosylation-deficient cells
12/09/2010WO2010141039A1 Isolation and purification of antibodies using protein a affinity chromatography
12/09/2010WO2010140387A1 Expression vector for establishing hyper-producing cells, and hyper-producing cells
12/09/2010WO2010140114A1 Monoclonal antibodies as a medicament for the therapeutic and/or prophylactic treatment of swine -origin influenza a (h1n1) virus (s-oiv) infections
12/09/2010WO2010139808A2 IMPROVED AMINO ACID SEQUENCES DIRECTED AGAINST HUMAN RESPIRATORY SYNCYTIAL VIRUS (hRSV) AND POLYPEPTIDES COMPRISING THE SAME FOR THE PREVENTION AND/OR TREATMENT OF RESPIRATORY TRACT INFECTIONS
12/09/2010WO2010139768A1 Sequences, antibodies, methods and kits for detection and in vitro assay of periostin, in order to provide a diagnosis, follow-up or prognosis of diseases and biological phenomena involving periostin
12/09/2010WO2010139742A1 TREATMENT OF ONCOSTATIN M RECEPTOR β MEDIATED HEART FAILURE
12/09/2010WO2010139469A2 Antibodies against human ccn1 and uses thereof
12/09/2010WO2010139193A1 Hand-foot-mouth disease vaccine, preparation method and uses thereof
12/09/2010WO2010139048A1 Human milk peptides
12/09/2010WO2010139047A1 Reagents and methods for detecting influenza virus proteins
12/09/2010WO2010106180A3 Optimized fc variants
12/09/2010WO2010089340A3 Peptides protective against e. faecalis, methods and uses relating thereto
12/09/2010WO2010022924A8 Antibodies against human epo receptor
12/09/2010US20100313300 Weed controller metabolism proteins, genes, thereof and use of the same
12/09/2010US20100313296 Method to improve plant resistance to infections
12/09/2010US20100313285 Altering High Density Lipoprotein Levels Through UDP-N-Acetyl-Alpha-D-Galactosamine: Polypeptide N-Acetlgalactosaminyltransferase (GALNT) Modulation
12/09/2010US20100313284 Means and methods for eliciting an immune response
12/09/2010US20100313283 Uses of gdnf and gdnf receptor
12/09/2010US20100313281 Variants and methods of using transforming growth factor beta-9
12/09/2010US20100311955 Humanized anti-human cd34 antibody, the preparation method and uses thereof
12/09/2010US20100311954 Optimized Proteins that Target Ep-CAM
12/09/2010US20100311953 Process for purifying proteins
12/09/2010US20100311669 Compounds that bind to p185 and methods of using the same
12/09/2010US20100311653 Splice variants of gdnf and uses thereof
12/09/2010US20100311189 Novel Receptor Nucleic Acids and Polypeptides
12/09/2010US20100311187 Antibody recognizing c-domain of midkine
12/09/2010US20100311169 Methods Of Generating High-Production Of Antibodies From Hybridomas Created By In Vitro Immunization
12/09/2010US20100311159 Methods for purifying or depleting molecules or cells of interest
12/09/2010US20100311120 Human cytokine receptor
12/09/2010US20100311119 Single-domain antigen-binding proteins that bind mammalian IgG
12/09/2010US20100311078 Immunoregulation in cancer, chronic inflammatory and autoimmune diseases
12/09/2010US20100311076 Method of binding proteins to carriers by making use of tamavidins
12/09/2010US20100311075 Human sodium-dependent bile acid transporter proteins
12/09/2010US20100311050 Compositions and methods for the diagnosis and treatment of tumor
12/09/2010US20100311045 Cancer
12/09/2010US20100310646 Selective exosite inhibition of papp-a activity against igfbp-4
12/09/2010US20100310638 Liposomes comprising duramycin and anti-viral agents
12/09/2010US20100310635 Compositions and Methods for Regulating T-Cell Activity
12/09/2010US20100310597 Anti-ofloxacin monoclonal antibody and immunoassay of ofloxacin using the same
12/09/2010US20100310584 Antigen
12/09/2010US20100310579 Method for inhibiting angiogenesis or for treatment of cancer
12/09/2010US20100310576 COMPOSITIONS AND METHODS COMPRISING ASPARTYL-tRNA SYNTHETASES HAVING NON-CANONICAL BIOLOGICAL ACTIVITIES
12/09/2010US20100310575 Inhibitors of Caspase I-Dependent Cytokines in the Treatment of Neurodegenerative Disorders
12/09/2010US20100310573 Anti-cd4 antibody
12/09/2010US20100310572 Binding molecules capable of neutralizing rabies virus and uses thereof
12/09/2010US20100310571 Uses of monoclonal antibody 8h9
12/09/2010US20100310569 Genes of an Otitis Media Isolate of Nontypeable Haemophilus Influenzae
12/09/2010US20100310567 Antibodies Against Human CCN1 and Uses Thereof
12/09/2010US20100310565 Antibodies that bind both il-17a and il-17f and methods of using the same
12/09/2010US20100310562 System for delivery into xcr1 positive cell and uses thereof
12/09/2010US20100310561 Natriuretic fusion proteins
12/09/2010US20100310559 Bind to human colorectal and pancreatic carcinoma-associated antigens (CPAA), diagnostics, vaccines; kits
12/09/2010US20100310558 Method for Linking Sequences of Interest
12/09/2010US20100310557 Antibodies immunoreactive with heregulin-coupled her3
12/09/2010US20100310553 Compositions and Methods for Controlling Hepatitis C Virus Infection
12/09/2010US20100310552 Antibodies produced in the avian oviduct
12/09/2010US20100310551 Immunogenic, monoclonal antibody
12/09/2010US20100310549 Inhibitors of type 2 vascular endothelial growth factor receptors
12/09/2010US20100310532 Gene targets in anti-aging therapy and tissue repair
12/09/2010US20100310501 Methods for Improving Immune Function and Methods for Prevention or Treatment of Disease in a Mammalian Subject
12/09/2010US20100310464 Antibodies
12/09/2010US20100310463 Anti-EpCAM Antibodies
12/09/2010CA2764398A1 Improved amino acid sequences directed against human respiratory syncytial virus (hrsv) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections
12/09/2010CA2764370A1 Fucosylation-deficient cells
12/09/2010CA2763977A1 Human milk peptides
12/09/2010CA2763935A1 Methods for identification of sites for igg conjugation
12/09/2010CA2762375A1 Antibodies against human ccn1 and uses thereof
12/09/2010CA2761959A1 Conjugation methods
12/09/2010CA2761733A1 Reagents and methods for detecting influenza virus proteins
12/09/2010CA2738498A1 Isolation and purification of antibodies using protein a affinity chromatography
12/08/2010EP2258869A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours
12/08/2010EP2258868A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours
12/08/2010EP2258867A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours
12/08/2010EP2258853A1 Lipolytic enzyme variant
12/08/2010EP2258852A1 Lipolytic enzyme variant
12/08/2010EP2258849A1 Mammalian receptor proteins; related reagents and methods
12/08/2010EP2258848A1 Il-17 homologous polypeptide and therapeutic uses thereof
12/08/2010EP2258842A1 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
12/08/2010EP2258835A1 Lipolytic enzyme variant
12/08/2010EP2258834A1 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis
12/08/2010EP2258728A1 Phosphorylcholine conjugates for use as vaccine
12/08/2010EP2258727A1 Immunoglobulin preparation for the treatment of autoimmune diseases and immune system disorders
12/08/2010EP2258726A1 High affinity human antibodies to c-erbB-2
12/08/2010EP2258725A2 Cytokine receptor zcytor17
12/08/2010EP2258724A1 Modulating immune responses using multimerized anti-CD83 antibodies
12/08/2010EP2258723A1 Treatment of oncostatin M receptor ß mediated heart failure
12/08/2010EP2258722A2 Antibodies to fibroblast growth factor-like (FGF-like) polypeptides
12/08/2010EP2258718A1 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
12/08/2010EP2258392A1 Method of administering therapeutic polypeptides
12/08/2010EP2257816A1 A method for characterization of a recombinant polyclonal protein
12/08/2010EP2257572A1 Human anti-mesothelin monoclonal antibodies
12/08/2010EP2257571A2 Compositions and methods for the therapy and diagnosis of cytomegalovirus infections
12/08/2010EP2257185A1 Methods and compositions of sphingolipid for preventing and treating microbial infections
12/08/2010EP1673397B1 Methods for the production and cytotoxicity evaluation of kir2dl nk-receptor antibodies